Bigpharma Dealmaking Handbook 2007

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Bigpharma - The Top 50

Chapter 3 - Most active bigpharma dealmakers

• 3.1 Bigpharma M&A activity
• 3.2 Bigpharma partnering

Chapter 4 - Top bigpharma deals - 2000-6

• 4.1 Bigpharma M&A
• 4.2 Bigpharma partnering

Chapter 5 - Submitting Opportunities to Bigpharma

• 5.1 How to submit an opportunity
• 5.2 Opportunity submission template
• 5.3 Sending emails
• 5.4 Face to face at partnering events
• 5.5 Online submission forms

Chapter 6 - Forthcoming bigpharma partnering events

• 6.1 Forthcoming events

Chapter 7 - Bigpharma company - therapy locator

• 7.1 How to use the therapy matrix tables
• 7.2 Therapeutic area definitions
• 7.3 Bigpharma - Therapeutic target matrix - marketed and pipeline compounds
• 7.5 Bigpharma - Therapeutic target matrix - expressed partnering interests
• 7.6 Bigpharma - Therapeutic target matrix - recent deals - 2005-2006

Chapter 8 - Bigpharma Company Profiles

• 8.1 How to use company profiles
• 8.2 Field definitions
• 8.3 Company profiles
  • Each profile includes:
    • Company contact details
    • Subsidiary companies
    • Primary therapy areas
    • Business development contacts
    • Company description
    • Marketed therapeutic indications
    • Pipeline (phase I-III) therapeutic indications
    • Partnering interests
    • Partnering interests - therapeutic indications
    • Partnering frequency per annum - 2000-2006
    • Current partner companies (2005-6)
    • Recent deals 2005-2006
      • By deal type
      • By stage of development
      • By therapy area
    • Contract documents available

Company profiles:

• Abbott
• Actavis
• Akzo Nobel
• Allergan
• Altana
• Amgen
• Astellas
• AstraZeneca
• Baxter International
• Bayer
• Bayer Schering Pharma AG
• Biogen Idec
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Cephalon
• Chugai
• CSL
• Dainippon Sumitomo
• Eisai
• Eli Lilly
• Forest Laboratories
• Genentech
• Genzyme
• Gilead Sciences
• GlaxoSmithKline
• Johnson & Johnson
• King
• Lundbeck
• Menarini
• Merck & Co
• Merck - Serono KGaA
• Mitsubishi
• Novartis AG
• Novo Nordisk
• Nycomed Pharma
• Otsuka
• Pfizer
• Procter & Gamble
• Roche
• Sanofi-Aventis
• Schering Plough
• Serono
• Shionogi Seiyaku
• Shire
• Solvay
• Takeda
• Tanabe Seiyaku
• TAP Pharmaceuticals
• Teva
• UCB
• Watson
• Wyeth

Chapter 9 - Resources

Appendices

• Appendix 1 - Example contract document

About CurrentPartnering

Recent titles from CurrentPartnering

Order form - Reports

Order form - Company Dealmaking Profiles

Order Form - Company Contract Sets

Order Form - contract sets

Order Form - contract documents

Order Form - Report update subscription

• Figure 1: Bigpharma - top 50 by pharma revenues 2006
• Figure 2: Additional bigpharma companies profiled in report
• Figure 3: Leading Bigpharma M&A companies, 2005-6
• Figure 4: Leading Bigpharma partnering companies, 2005-6
• Figure 5: Leading M&A deals by value, 2005-6
• Figure 6: Leading partnering deals by value, 2005-6
• Figure 7: Typical partnering opportunity submission template
• Figure 8: Partnering events 2007-8
• Figure 9: Therapeutic area definitions
• Figure 10: Therapeutic target matrix - marketed and pipeline compounds
• Figure 11: Therapeutic target matrix - expressed partnering interests
• Figure 12: Therapeutic target matrix - recent deals 2005-6
• Figure 13: Company profile template and definitions used in report
• Figure 14: Online partnering resources
• Figure 15: Development and license agreement between Boehringer Ingelheim and Inspire Pharmaceuticals, February 2006